Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | ATF5 |
| Upstream (Parents) |
|---|
| (<<) SLC17A2 → ATF5 |
| (<<) APOC4 → ATF5 |
| Downstream (Children) |
|---|
| ATF5 → TNFSF14 (>>) |
| ATF5 → EPO (>>) |
| ATF5 → SEMA4D (>>) |
| ATF5 → ANGPTL4 (>>) |
| ATF5 → CYP21A2 (>>) |
| ATF5 → G0S2 (>>) |
| ATF5 → CEBPD (>>) |
| ATF5 → ANKRD55 (>>) |
| ATF5 → DYRK2 (>>) |
| ATF5 → GNL3L (>>) |
| ATF5 → CS (>>) |
| ATF5 → PQLC1 (>>) |
| ATF5 → FGF21 (>>) |
| ATF5 → VKORC1 (>>) |
